Low-code Accelerates Pharma Innovation and Process Automation
Low-code platforms empower pharmaceutical companies with tools for rapid software development, process automation, and adaptation to regulatory changes.
Scriptum has published an article exploring the potential of low-code platforms within the pharmaceutical industry. Low-code is a software development technology that enables the creation of applications using visual tools and pre-built templates, minimizing the need for extensive coding expertise.
This approach allows pharmaceutical companies to accelerate innovation, automate specific processes, and adapt more effectively to dynamic market shifts and regulatory requirements. For Ukrainian businesses, particularly in the pharmaceutical sector, implementing low-code solutions can be highly relevant. It allows for a significant reduction in time and cost for developing critical software products, a crucial factor amidst limited resources. Furthermore, low-code facilitates rapid adaptation to evolving regulatory demands and ensures efficient digitalization of internal processes, enhancing companies’ market competitiveness.
Key Application Areas for Low-code in Pharmaceuticals:
- Automation of research processes (clinical trial data management, visualization).
- Supply chain management (drug tracking, shipment monitoring).
- Ensuring regulatory compliance (report automation, tracking regulatory changes).
- Optimization of internal business processes (document management, HR, financial accounting).
- Improving customer interaction (mobile applications, CRM systems).
Learn more about the capabilities of low-code in the pharmaceutical industry in the full article: Scriptum
Source: Scriptum